The Tellurium-based Immunomodulator, AS101 Ameliorates Adjuvant-Induced Arthritis in Rats.

CONCLUSION: Taken together, we report the first demonstration of the anti-rheumatic/inflammatory activity of AS101 in experimental RA model thereby supporting an alternative early therapeutic intervention and identifying a promising agent for therapeutic intervention.
PMID: 33205391 [PubMed - as supplied by publisher]

Source: Clinical and Developmental Immunology - November 18, 2020 Category: Allergy & Immunology Authors: Halpert G, Halperin Sheinfeld M, Monteran L, Sharif K, Volkov A, Nadler R, Schlesinger A, Barshak I, Kalechman Y, Blank M, Shoenfeld Y, Amital H Tags: Clin Exp Immunol Source Type: research